Physical Medicine & Rehabilitation Research - Copenhagen, Department of Occupational Therapy and Physiotherapy, Copenhagen University Hospital Amager and Hvidovre, 2650, Hvidovre, Denmark.
Unit for Dietetics and Nutrition Research, Copenhagen University Hospital Herlev and Gentofte, 2730, Herlev, Denmark.
Clin Nutr ESPEN. 2022 Jun;49:551-555. doi: 10.1016/j.clnesp.2022.03.039. Epub 2022 Apr 6.
BACKGROUND & AIMS: It is well known that oropharyngeal dysphagia (OD) challenges eating, drinking, and swallowing by penetration to the airway. In clinical practice, thickening agents in liquid and texture modified diets are used to reduce pneumonia and secure nutritional status. The scientific evidence on this OD management is, however, limited. In 2016 we updated an original clinical guideline on OD in adults. Based on the strength of the evidence of two randomized control trials (RCTs), we provided a weak clinical recommendation against the use of thickening agents for liquid and none for diet. In the hope of finding new scientific evidence, we aimed to update the clinical guideline by examining the evidence if thickening of liquid and diet 1) improve survival and quality of life, 2) reduce the occurrence of aspiration risk and pneumonia, 3) improve dehydration, nutritional status, and mealtime performance, and 4) relate to patient preferences and intervention adherence.
We performed a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. We first searched systematic reviews and meta-analyses, and secondly, the primary literature of RCTs. We undertook the search in PubMed, Embase, CINAHL, Cochrane Database of Systematic Reviews, and Cochrane Central Register of Controlled Trials from January 1, 2015, to May 19, 2021. The quality of the evidence was evaluated using the revised Cochrane risk-of-bias tool and the GRADE (Grading of Recommendations: Assessment, Development and Evaluation) approach.
One new study was included, resulting in a total of three RCTs, of which two were already included in our former guideline. The three studies focused on the thickening of liquid, but no change of the former weak recommendation against the thickening of liquid could be made due to the quality of evidence evaluation.
There is no convincing evidence that thickened liquid or texture modified diet prevents death or pneumonia nor improves the quality of life, nutritional status, or oral intake in individuals with OD. There is a need for future studies to examine the effect and discuss outcome measures in OD management with thickening agents.
众所周知,口咽吞咽困难(OD)会导致食物、饮料和吞咽物穿透气道,从而对进食、饮水和吞咽造成挑战。在临床实践中,会使用增稠剂来增加液体的稠度并改变食物质地,以降低肺炎的发生风险并确保营养状况。然而,目前关于 OD 管理的科学证据非常有限。2016 年,我们更新了一份关于成人 OD 的临床指南。基于两项随机对照试验(RCT)的证据强度,我们提供了一项关于液体增稠剂使用的弱临床推荐,不推荐用于饮食。我们希望找到新的科学证据,因此,我们旨在通过检查液体和饮食增稠 1)是否改善生存和生活质量,2)降低误吸风险和肺炎发生风险,3)改善脱水、营养状况和用餐表现,以及 4)与患者偏好和干预依从性相关的证据来更新临床指南。
我们按照系统评价和荟萃分析的首选报告项目(PRISMA)检查表进行了系统评价。我们首先搜索了系统评价和荟萃分析,其次搜索了 RCT 的原始文献。我们在 PubMed、Embase、CINAHL、Cochrane 系统评价数据库和 Cochrane 对照试验中心注册库中进行了搜索,检索时间为 2015 年 1 月 1 日至 2021 年 5 月 19 日。使用修订后的 Cochrane 偏倚风险工具和 GRADE(推荐评估、制定与评价)方法评估证据质量。
纳入了一项新的研究,共纳入了三项 RCT,其中两项已经包含在我们之前的指南中。这三项研究都集中在液体增稠方面,但由于证据质量评估,我们不能对之前反对液体增稠的弱推荐进行修改。
没有令人信服的证据表明增稠液体或质地改变饮食可以预防死亡或肺炎,也不能改善 OD 患者的生活质量、营养状况或口服摄入。未来需要研究来检验增稠剂在 OD 管理中的效果,并讨论其结局指标。